Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News

More articles from Targeting Drug Resistance: Poster Presentations - Proffered Abstracts

  • Abstract B50: Preclinical efficacy of combined MEK and Src inhibition: MEK inhibitor reverses resistance to Src inhibitor therapy in ovarian cancer cells
    Fiona Simpkins, Diana Azzam, Joyce M. Slingerland
    Clinical Cancer Research Oct 2013, 19 (19 Supplement) B50; DOI: 10.1158/1078-0432.OVCA13-B50
  • Abstract B48: Targeting chemo-resistance in CCNE1-amplified ovarian cancer
    Barbie Taylor-Harding, Hasmik Agadjanian, Paul Joseph Aspuria, Takako Mizuno, Dong-Joo Cheon, Sandra Orsulic, Beth Karlan, Christine Walsh, Wolf Ruprecht Wiedemeyer
    Clinical Cancer Research Oct 2013, 19 (19 Supplement) B48; DOI: 10.1158/1078-0432.OVCA13-B48
  • Abstract B52: The bromodomain inhibitor JQ1 enhances cisplatin-mediated cytotoxicity in ovarian cancer cells
    Dineo Khabele, Andrew J. Wilson, Jeanette Saskowski, Scott W. Hiebert
    Clinical Cancer Research Oct 2013, 19 (19 Supplement) B52; DOI: 10.1158/1078-0432.OVCA13-B52
  • Abstract B51: Management of ascites via the alfa-pump closed system in platinum-resistant-ovarian-cancer (PROC): A model of sequential non-invasive tumor-cell sampling through the urinary bladder
    Christina Fotopoulou, Laura Spiers, Delali Adjogatse, Emily Pickford, Roberto Dina, Sara Blagden, Nagy Habib, Hani Gabra
    Clinical Cancer Research Oct 2013, 19 (19 Supplement) B51; DOI: 10.1158/1078-0432.OVCA13-B51
  • Abstract B49: The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer
    Jimmy Belotte, Nicole Fletcher, Awoniyi Awonuga, Mitchell Alexis, Husam Abu-soud, Michael Diamond, Mohammed Saed, Ghassan Saed
    Clinical Cancer Research Oct 2013, 19 (19 Supplement) B49; DOI: 10.1158/1078-0432.OVCA13-B49
  • Abstract B44: Mapping, targeting, and eliminating therapeutically unresponsive ovarian cancer with high content imaging and photodynamic therapy
    Hsin-I Hung, Oliver J. Klein, Yookyung Jung, Kashmira S. Kulkarni, Bo R. Rueda, Rosemary Foster, Conor L. Evans
    Clinical Cancer Research Oct 2013, 19 (19 Supplement) B44; DOI: 10.1158/1078-0432.OVCA13-B44
  • Abstract B32: The role of the glucocorticoid receptor (GR) in inhibiting chemotherapy-induced apoptosis in high-grade serous ovarian carcinoma (HGS-OvCa)
    Erica M. Stringer, Maxell N. Skor, Lei Zhao, Katja Gwin, Ernst Lengyel, Gini F. Fleming, Suzanne D. Conzen
    Clinical Cancer Research Oct 2013, 19 (19 Supplement) B32; DOI: 10.1158/1078-0432.OVCA13-B32
  • Abstract A53: Biomarkers of chemotherapy resistance in serous epithelial ovarian cancer identified by integrative genomic and transcriptomic analysis
    Madhuri Koti, Robert J. Gooding, Paulo Nuin, Alexandria Haslehurst, Colleen Crane, Johanne Weberpals, Timothy Chids, Peter Bryson, Moyez Dharsee, Kenneth R. Evans, Harriet E. Feilotter, Paul C. Park, Jeremy A. Squire
    Clinical Cancer Research Oct 2013, 19 (19 Supplement) A53; DOI: 10.1158/1078-0432.OVCA13-A53
  • Abstract B40: MiR-30c-2-3p participates in a regulatory feedback loop to inhibit the progression of chemoresistant ovarian cancer cells
    Mandi Murph, Wei JIa, Molly Altman, Ha Nguyen
    Clinical Cancer Research Oct 2013, 19 (19 Supplement) B40; DOI: 10.1158/1078-0432.OVCA13-B40
  • Abstract A49: Adipocytes promote ovarian cancer cell chemoresistance
    Jiang Yang, Marsha A. Moses
    Clinical Cancer Research Oct 2013, 19 (19 Supplement) A49; DOI: 10.1158/1078-0432.OVCA13-A49

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement